Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000930 · ClinicalTrials.gov registry record

A Study of HIV in Newly Infected Individuals

A clinical trial of HIV Infections, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
12
Study locations

NCT00000930: Completed study of HIV Infections, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

NCT00000930 is a study of HIV Infections that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The trial reports 12 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000930, a study of HIV Infections, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
12
Study locations

Study Summary

The purpose of this study is to see how HIV reacts in the immune systems of patients who have recently been infected with HIV. This study also examines HIV's resistance to anti-HIV drugs in newly infected patients. Certain populations are good candidates for participation in HIV vaccine trials. These groups include men who have sex with men, IV drug users, and women at risk of getting HIV through heterosexual contact. Learning how HIV behaves in these populations once they become infected can help with the planning of future HIV vaccine studies.

Conditions Studied

HIV Infections

Study Locations (12)

New York

  • New York Univ Med Ctr - New York
  • Bronx-Lebanon Hosp Ctr - The Bronx
  • New York Blood Ctr - The Bronx

California

  • Los Angeles County / Health Research Assoc / Drew Med Ctr - Los Angeles
  • San Francisco Dept of Hlth / AIDS Office - San Francisco

Colorado

  • Denver Dept of Public Health / HIVNET - Denver

Illinois

  • Univ of Illinois Chicago / Howard Brown Hlth Ctr - Chicago

Maryland

  • Johns Hopkins Univ - Baltimore

Massachusetts

  • Fenway Community Health Ctr / HIVNET - Boston

Pennsylvania

  • Univ of Pennsylvania / HIVNET - Philadelphia

Rhode Island

  • Miriam Hosp - Providence

Trial Details

FieldValue
Est. Completion 2008-05
National Institute of Allergy and Infectious Diseases (NIAID)

2,006 total trials

What the finished NCT00000930 record still lists

NCT00000930 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.

NCT00000930 lists 12 locations in 9 states (New York, California, Colorado).

Frequently Asked Questions

What is clinical trial NCT00000930 about?

NCT00000930 is a clinical study titled "A Study of HIV in Newly Infected Individuals". The purpose of this study is to see how HIV reacts in the immune systems of patients who have recently been infected with HIV. This study also examines HIV's resistance to anti-HIV drugs in newly infected patients. Certain populations are good candidates for participation in HIV vaccine trials. The...

What is the current status of trial NCT00000930?

This trial is currently completed. Estimated completion is 2008-05.

What conditions does trial NCT00000930 study?

This clinical trial studies the following conditions: HIV Infections.

Who is sponsoring clinical trial NCT00000930?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00000930 being conducted?

This trial has 12 study locations across California, Colorado, Illinois, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Related registry views

Source: ClinicalTrials.gov NCT00000930, the US trial registry maintained by the National Library of Medicine. NCT00000930 (unsized enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.